Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored tablets

Neo Borocillina Gola Dolore 8.75mg is a flurbiprofen -based tablet medicine, indicated for the symptomatic treatment of sore throat associated with pain and inflammation. Thanks to its analgesic and anti-inflammatory action, it quickly reduces pain and discomfort in the throat, promoting the well-being of the oral mucosa. The sugar-free mint-flavored tablets are ideal for those looking for a practical and fresh-tasting remedy, also suitable for those following a low-sugar diet.

ACTIVE INGREDIENTS

Active ingredients contained in Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges - What is the active ingredient in Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges?

NEO BOROCILLINA GOLA DOLORE 0.25% mouthwash and NEO BOROCILLINA GOLA DOLORE 0.25% oral mucosa spray (all presentations) 100 ml of solution contain: Active ingredient: Flurbiprofen 0.25 g. Excipients with known effects: ethanol 9.60 g; liquid sorbitol (non-crystallizable) 7.00 g; methyl-p-hydroxybenzoate 0.10 g; propyl-p-hydroxybenzoate 0.02 g; glycerol 10 g; sodium 6.8 mg. NEO BOROCILLINA GOLA DOLORE 0.25% oral mucosa spray orange and honey flavour and NEO BOROCILLINA GOLA DOLORE 0.25% oral mucosa spray lemon and honey flavour also contain the excipient with known effect sunset yellow (E110): 100 ml of solution contain: sunset yellow (E110): 0.014 g (presentation 0.25% oral mucosa spray orange and honey flavour); 0.006 g (presentation 0.25% oral mucosa spray lemon and honey flavour) For the full list of excipients, see section 6.1 NEO BOROCILLINA GOLA DOLORE 8.75 mg lozenges (all presentations) One lozenge contains: Active ingredient: Flurbiprofen 8.75 mg. Excipients with known effect : glycerol 20 mg; isomalt 931.45 mg (orange and honey flavour); 936.45 mg (lemon and honey flavour); 913.25 mg (mint flavour). For the full list of excipients, see section 6.1

EXCIPIENTS

Composition of Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges - What does Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges contain?

Mouthwash and oral mucosa spray, mint flavour Glycerol , ethyl alcohol ( ethanol 96%), liquid sorbitol (non-crystallizable), polyoxyethylene hydrogenated castor oil 40, sodium hydroxide, sodium saccharin, methyl-p-hydroxybenzoate, propyl-p-hydroxybenzoate, trirectified mint essential oil, patent blue V (E 131), citric acid, purified water. Lemon and honey flavoured oral mucosa spray Glycerol, ethyl alcohol ( ethanol 96%), liquid sorbitol (non-crystallizable), polyoxyethylene hydrogenated castor oil 40, sodium hydroxide, sodium saccharin, methyl-p-hydroxybenzoate, propyl-p-hydroxybenzoate, honey flavouring, lemon flavouring, mint flavouring, sunset yellow (E110 ), citric acid, purified water. Orange and honey flavoured oral mucosa spray Glycerol , ethyl alcohol ( ethanol 96%), liquid sorbitol (non-crystallisable), polyoxyethylene hydrogenated castor oil 40, sodium hydroxide, sodium saccharin, methyl-p-hydroxybenzoate, propyl-p-hydroxybenzoate , honey flavouring, orange flavouring, mint flavouring, sunset yellow (E110) , citric acid, purified water. Sugar-free mint flavoured lozenges Glycerol dibehenate, acesulfame potassium, balsamic mint flavouring, isomalt , copovidone. Sugar-free lemon and honey flavoured lozenges Glycerol dibehenate, acesulfame potassium, lemon honey flavouring, isomalt , copovidone. Sugar-free orange and honey flavoured lozenges Glycerol dibehenate, acesulfame potassium, orange honey flavouring, isomalt , copovidone.

DIRECTIONS

Therapeutic indications Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges - Why is Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges used? What is it for?

NEO BOROCILLINA GOLA DOLORE mouthwash / NEO BOROCILLINA GOLA DOLORE oral mucosa spray is used in the symptomatic treatment of irritative-inflammatory conditions also associated with pain in the oropharyngeal cavity (e.g. gingivitis, stomatitis, pharyngitis), also as a consequence of conservative or extractive dental therapy. NEO BOROCILLINA GOLA DOLORE lozenges are used in the symptomatic treatment of irritative-inflammatory conditions also associated with pain in the oropharyngeal cavity (e.g. gingivitis, stomatitis, pharyngitis).

CONTRAINDICATIONS SIDE EFFECTS

Contraindications Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges - When should Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges not be used?

Flurbiprofen is contraindicated in patients with hypersensitivity (asthma, bronchospasm, urticaria or allergic type) to flurbiprofen or to any of the excipients, and to acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs (NSAIDs). Third trimester of pregnancy. Administration of flurbiprofen is not recommended in nursing mothers. Do not use in patients who suffer from peptic ulcer or who have suffered from it in the past. Do not administer the tablets to children under 12 years of age.

DOSAGE

Quantity and method of taking Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges - How do you take Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges?

Mouthwash The recommended dose is 2-3 rinses or gargles a day with 10 ml of mouthwash (using the appropriate measuring cup), diluted in half a glass of water or pure. Oral mucosa spray The recommended dose is 2 sprays 3 times a day directed directly at the affected area; each spray delivers 0.2 ml of solution, equivalent to 0.5 mg of active ingredient. Lozenges Adults and children over 12 years: 1 lozenge to dissolve slowly in the mouth every 3-6 hours, as needed. Do not exceed the dose of 8 lozenges in 24 hours. Do not administer to children under 12 years of age. No dosage changes are necessary for elderly people.

CONSERVATION

Storage Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges - How do you store Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges?

Mouthwash and oral mucosa spray: No special storage conditions. Tablets: Store at a temperature not exceeding 25°C.

WARNINGS

Warnings Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges - About Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges it is important to know that:

At the recommended doses, when using the medicine in its various pharmaceutical forms, any swallowing does not, in itself, cause any harm to the patient, as these doses are much lower than those commonly used in treatments with systemic flurbiprofen. In patients with renal, cardiac or hepatic insufficiency, the medicine NEO BOROCILLINA GOLA DOLORE must be used with caution. It is recommended not to combine the medicine with NSAIDs. Use, especially if prolonged, of the product may give rise to sensitization or local irritation phenomena; in such cases, it is necessary to interrupt the treatment and consult the doctor to establish, if necessary, an appropriate therapy. Do not use for prolonged treatments. After a short period of treatment without appreciable results, consult the doctor. NEO BOROCILLINA GOLA DOLORE mouthwash and NEO BOROCILLINA GOLA DOLORE oral mucosa spray (all presentations) contain: - 960 mg of ethanol per 10 ml of mouthwash. May cause a burning sensation on damaged skin. - hydrogenated polyoxydated castor oil which may cause localised skin reactions. - parahydroxy benzoates which may cause allergic reactions (possibly delayed). NEO BOROCILLINA GOLA DOLORE 0.25% spray for the oral mucosa, orange and honey flavour and NEO BOROCILLINA GOLA DOLORE 0.25% spray for the oral mucosa, lemon and honey flavour also contain the colouring sunset yellow (E110), which may cause allergic reactions. NEO BOROCILLINA GOLA DOLORE 8.75 mg lozenges (all presentations) contain isomalt: patients with rare hereditary problems of fructose intolerance should not take this medicine.

INTERACTIONS

Interactions Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges - Which medicines or foods can modify the effect of Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges?

Inform your doctor if you are taking other medications. As demonstrated in some clinical studies, flurbiprofen may occasionally reduce the diuretic activity of furosemide. In addition, flurbiprofen may occasionally interfere with the action of anticoagulant drugs. However, no interaction of flurbiprofen with digoxin, tolbutamide and antacids has been demonstrated.

SIDE EFFECTS

Like all medicines, Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint flavour pastilles can cause side effects - What are the side effects of Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint flavour pastilles?

The use of NEO BOROCILLINA GOLA DOLORE, especially if prolonged, may give rise to sensitization or local irritation phenomena; in such cases, treatment should be interrupted and, if necessary, appropriate therapy should be instituted. The following undesirable effects have been reported, particularly after the administration of higher doses systemically: Blood and lymphatic system disorders Thrombocytopenia, aplastic anemia and agranulocytosis. Immune system disorders Anaphylaxis, angioedema, allergic reaction. Nervous system disorders Dizziness, cerebrovascular accidents, visual disturbances, optic neuritis, migraine, paraesthesia, depression, confusion, hallucination, vertigo, discomfort, fatigue and drowsiness. Ear and labyrinth disorders Tinnitus. Respiratory, thoracic and mediastinal disorders Respiratory tract reactivity (asthma, bronchospasm and dyspnoea). Gastrointestinal disorders The most commonly observed adverse events are gastrointestinal in nature. Nausea, vomiting, diarrhoea, flatulence, constipation, dyspepsia, abdominal pain, melaena, haematemesis, ulcerative stomatitis, gastrointestinal haemorrhage and exacerbation of colitis and Crohn's disease have been reported following administration of flurbiprofen. Less frequently, gastritis, peptic ulcer, perforation and ulcer haemorrhage have been observed. Skin and subcutaneous tissue disorders Skin disorders including rash, pruritus, urticaria, purpura and very rarely bullous dermatoses (including Stevens-Johnson syndrome, toxic epidermal necrolysis and erythema multiforme). Renal and urinary disorders Nephrotoxicity in various forms, including interstitial nephritis and nephrotic syndrome. As with other NSAIDs, rare cases of renal failure have been reported. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse

OVERDOSE

Overdose Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges - What are the risks of Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges in case of overdose?

With the use of NEO BOROCILLINA GOLA DOLORE it is rare that overdose situations may occur. Symptoms Symptoms of overdose may include nausea, vomiting and gastrointestinal irritation. Treatment Treatment should include gastric lavage and, if necessary, correction of the serum electrolyte profile. There is no specific antidote for flurbiprofen.

PREGNANCY AND BREASTFEEDING

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavoured lozenges.

During the first and second trimester of pregnancy, flurbiprofen should not be administered unless clearly necessary. The drug administered during pregnancy may delay the onset of labor and increase its duration. Administration of flurbiprofen is not recommended in nursing mothers.

DRIVING AND USE OF MACHINERY

Taking Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges before driving or using machinery - Does Neo Borocillina Gola Dolore 8.75mg 32 sugar-free mint-flavored lozenges affect driving or using machinery?

The medicine does not alter the ability to drive vehicles or use machines.